Profile picture

Mr Robert Hokanson

Medtronic, Minneapolis (United States of America)
Follow
Logo ESC

Contributor content

Incidence and significance of early AF recurrences with the second generation cryoballoon: insights from the STOP-AF post approval study
Presentation
Incidence and significance of early AF recurrences with the second generation cryoballoon: insights from the STOP-AF post approval study
Read more
Second generation cryoballoon ablation in paroxysmal atrial fibrillation patients: 24 month safety and efficacy from the STOP-AF post approval study
Presentation
Second generation cryoballoon ablation in paroxysmal atrial fibrillation patients: 24 month safety and efficacy from the STOP-AF post approval study
Read more

ESC 365 is supported by

novartis Explore sponsored resources